Drugs, Cosmetics & Health Care
Ethical Drug Manufacturers
Fiscal Year Ends:
24 (oh gott, verdammt kleiner Laden ?)
Total Shares Outstanding:
Closely Held Shares:
Wright Quality Rating:
advanced Viral Research Corp. was incorporated to produce, market, promote and sell a pharmaceutical drug with the trade name "Reticulose". Reticulose is an anti-viral peptide-nucleic acid complex preparation used in the treatment of Asian Influenza, Viral Pneumonia, Virus Infectious Hepatitis, Mumps etc. The company's operations in the recent years have been
limited principally to engaging in research, in vitro testing and analysis of Reticulose on human patients overseas. The company has granted distribution rights for Reticulose in certain foreign countries.
The company is in the developmental stage, and has not yet commenced
commercial operations. It is dependent on registration and/or approval by applicable regulatory authorities of Reticulose, of which there can be no assurance.
Na, das ist zwar alles sehr positiv, aber hört sich verdammt riskant an.
Aber vielleicht sind das nicht die latest-news ?
weiteres folgt, so ich es finde..